This document discusses anti-counterfeiting strategies as both a business opportunity and obligation. It argues that counterfeiters are commercial competitors who undermine brand value, and that product security can differentiate brands by assuring quality, safety and authenticity. The document also suggests improving business processes through anti-counterfeiting efforts, noting most processes can be strengthened by examining costs and linking up steps without shortcuts.
2. AgendaPersonal background & introductionCounterfeiters as commercial competitorsProduct security as a differentiatorImproving business processes with brand protectionAnti-counterfeiting as customer servicemark.davison@bluespherehealth.com2
3. Personal background22 years in healthcare, 5 years product securityAuthor: Pharmaceutical Anti-Counterfeiting (Wiley, New York, June 2011)Serialisation: Opportunity or Perfect Storm? (SecuringPharma.com, April2011)Seminar Leader: Authentication Academy (London, 23-24 June 2011, Heathrow Windsor Marriott)mark.davison@bluespherehealth.com3
17. Security = OpportunityExamine ALL costs and liabilitiesBrand paternalism is deadCommunication is instant, global and loudmark.davison@bluespherehealth.com17
18. Security = DifferentiatorQuality, safety, authenticityLegitimate products vs. fake productsnotBrands competing to be safer than each othermark.davison@bluespherehealth.com18
28. Counterfeiting is an obvious threatCriminal, technological, process counter-measuresAnti-counterfeiting is a clear obligationbut also an opportunity to improve our businessesmark.davison@bluespherehealth.com28
29. Authentication Academy23-24 June 2011LondonHeathrow Windsor Marriottwww.authenticationacademy.comwww.agoralive.com/bluespherehealth/event1(to register directly)mark.davison@bluespherehealth.com29
Editor's Notes
#3: Interactive discussion, not lecture-styleQuestions as we go
#4: Book will be available from Blue Sphere website or through all good bookshops
#18: Examine ALL costs and liabilitiesDoing nothing is not a cost-free optionPharmaceutical paternalism is deadDoctor doesnt know best any morePatients know best (or at least want to be heard) Communication is instant, global and loudBrands have good and bad days butdialogue with customers is better than just listening
#19: Find ways to emphasise and publicise qualityCollective action
#22: Do you need all those different suppliers?Does your packaging need to be that design / shape / material?Do suppliers do what they say they do, when you arent there to check?
#23: Make sure the end result is a coherent process that works for the business and the customer
#27: If brand owners and other stakeholders dont act soon, the room to manoeuvre may become limited.There are a finite number of solution providers and partners for pilot studies.Drastic is a memorable acronym for some of the main elements that need to be addressed.